Because Rgs regulation of GPCR signaling is ubiquitous during embryonic and childhood development, and adult life, the approach of using Rgs reporter genes to understand PDA is broadly applicable to identifying therapeutic interventions for the treatment of many cancers and disease conditions. This evidence concerns the gene PITX2 and cancer.